SJ Medical
SJ Medical
Leading Interventional Cardiology Devices for the Malaysian Healthcare Sector
As a leading Drug-Eluting Stents (DES) supplier and exporter in Malaysia, we recognize the critical role these medical devices play in the nation's healthcare system. Malaysia is currently witnessing a significant shift in its medical device landscape, driven by a growing prevalence of cardiovascular diseases (CVD). According to the National Heart Association of Malaysia (NHAM), heart disease remains the leading cause of death in the country, necessitating advanced interventional solutions like third-generation drug-eluting stents.
The Malaysian market is characterized by a sophisticated regulatory environment overseen by the Medical Device Authority (MDA). Any DES system entering the local market must adhere to stringent quality benchmarks to ensure patient safety in high-traffic medical hubs like Kuala Lumpur, Penang, and Johor Bahru. Our commitment to excellence aligns with Malaysia's 12th Malaysia Plan, which emphasizes strengthening the domestic medical technology manufacturing and supply chain to become a regional healthcare hub in Southeast Asia.
The demand for DES in Malaysia is projected to grow at a CAGR of 7.5% due to an aging population and increased access to private healthcare facilities like KPJ and IHH Healthcare.
Clinicians are moving toward Polymer-Free and Bioresorbable technologies to minimize late-stent thrombosis, a key focus for our R&D team.
Leveraging Malaysia's world-class ports (Port Klang & PTP), we ensure seamless export and distribution of life-saving stent systems across the ASEAN region.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
Our Drug-Eluting Stents utilize precision Sirolimus-eluting technology. Sirolimus is a proven anti-proliferative agent that effectively reduces neointimal hyperplasia. By employing a polymer-free or biocompatible polymer base, our stents ensure a controlled release of medication, which is vital for the long-term success of percutaneous coronary interventions (PCI) performed in Malaysia’s top cardiac centers like the National Heart Institute (IJN).
Understanding the complexities of calcified lesions often encountered in the local patient demographic, our stents are designed with a low-profile delivery system and enhanced flexibility. This ensures that surgeons can navigate through tortuous vessels with ease, reducing procedure time and improving clinical outcomes.
We adhere to the highest international standards, including ISO 13485 and CE Certification. Each stent undergoes rigorous testing, from fatigue resistance to coating integrity. For the Malaysian market, we ensure our documentation meets every requirement of the Medical Device Authority (MDA), providing peace of mind to hospital procurement departments and distributors alike.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop.
The company has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval, along with free sale certificates, demonstrating our commitment to quality.
Long-term partnerships with clients across Europe, Asia (Indonesia, India, Malaysia), the Middle East, and Africa. We continue to strengthen our global presence.
The interventional cardiology market in Malaysia is undergoing a digital and technological transformation. With the rise of Medical Tourism, hospitals in Melaka and Penang are attracting international patients from neighboring Indonesia and Vietnam for complex cardiac procedures. This demand necessitates a reliable supply of high-end Drug-Eluting Stents that offer both efficacy and affordability.
Innovation in "Smart Stents" and the integration of AI in diagnostic tools (such as our Handheld Ultrasound Imaging System) are becoming trends in Malaysia's private healthcare sector. Providers are looking for integrated solutions where the stent, the balloon catheter, and the imaging tools work in synergy to provide a holistic treatment pathway.
Furthermore, Malaysia’s focus on Halal-certified medical consumables and ethically sourced materials is a unique aspect of the local market. While stents are generally metallic, the coatings and manufacturing processes are scrutinized for biocompatibility and ethical standards, areas where Hangzhou SJ Medical excels.
As we look toward 2025, the synergy between Chinese manufacturing excellence and Malaysian clinical expertise will likely drive the next wave of healthcare cost-optimization. By providing premium DES at competitive prices, we help Malaysian hospitals manage their budget without compromising on the Gold Standard of patient care.
Comprehensive Vascular & Rehabilitation Equipment for Global Distribution
We provide end-to-end support for medical distributors and hospitals in Malaysia. From technical specifications to MDA registration assistance, SJ Medical is your trusted partner in vascular intervention.
Send Inquiry Now
